DE60236294D1 - Neue 2h-pyridazin-3-on derivate, pharmazeutische zusammensetzungen davon sowie ein verfahren zur herstellung derselben - Google Patents

Neue 2h-pyridazin-3-on derivate, pharmazeutische zusammensetzungen davon sowie ein verfahren zur herstellung derselben

Info

Publication number
DE60236294D1
DE60236294D1 DE60236294T DE60236294T DE60236294D1 DE 60236294 D1 DE60236294 D1 DE 60236294D1 DE 60236294 T DE60236294 T DE 60236294T DE 60236294 T DE60236294 T DE 60236294T DE 60236294 D1 DE60236294 D1 DE 60236294D1
Authority
DE
Germany
Prior art keywords
pyridazin
derivatives
new
production
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60236294T
Other languages
English (en)
Inventor
Jozsef Barkoczy
Nagy Peter Kotay
Gyula Simig
Gyoergy Levay
Istvan Gacsalyi
Andras Egyed
Bajnogel Judit Raczne
Katalin Pallagi
Eva Schmidt
Gabor Szenasi
Kovacs Aniko Miklosne
Janos Wellmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Pharmaceuticals PLC filed Critical Egis Pharmaceuticals PLC
Application granted granted Critical
Publication of DE60236294D1 publication Critical patent/DE60236294D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60236294T 2001-07-26 2002-07-24 Neue 2h-pyridazin-3-on derivate, pharmazeutische zusammensetzungen davon sowie ein verfahren zur herstellung derselben Expired - Lifetime DE60236294D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0103063A HU225955B1 (en) 2001-07-26 2001-07-26 Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them
PCT/HU2002/000072 WO2003010166A1 (en) 2001-07-26 2002-07-24 Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient

Publications (1)

Publication Number Publication Date
DE60236294D1 true DE60236294D1 (de) 2010-06-17

Family

ID=89979562

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60236294T Expired - Lifetime DE60236294D1 (de) 2001-07-26 2002-07-24 Neue 2h-pyridazin-3-on derivate, pharmazeutische zusammensetzungen davon sowie ein verfahren zur herstellung derselben

Country Status (28)

Country Link
US (1) US7098210B2 (de)
EP (1) EP1417206B1 (de)
JP (1) JP4249012B2 (de)
KR (1) KR100909514B1 (de)
CN (1) CN1247571C (de)
AR (2) AR036248A1 (de)
AT (1) ATE466859T1 (de)
AU (1) AU2002321669B8 (de)
BR (1) BR0211440A (de)
CA (1) CA2453917C (de)
CY (1) CY1110240T1 (de)
CZ (1) CZ2004123A3 (de)
DE (1) DE60236294D1 (de)
DK (1) DK1417206T3 (de)
EA (1) EA006246B1 (de)
ES (1) ES2345541T3 (de)
HK (1) HK1067626A1 (de)
HU (1) HU225955B1 (de)
MA (1) MA27867A1 (de)
MX (1) MXPA04000814A (de)
NO (1) NO326155B1 (de)
NZ (1) NZ531154A (de)
PL (1) PL206824B1 (de)
PT (1) PT1417206E (de)
SI (1) SI1417206T1 (de)
SK (1) SK552004A3 (de)
WO (1) WO2003010166A1 (de)
ZA (1) ZA200400482B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227255B1 (en) * 2002-04-26 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Novel piperidine-alkyl-amino-pyridazine derivatives, pharmaceutical compositions containing the same and process for the preparation of the active ingredient
US7852298B2 (en) 2005-06-08 2010-12-14 Ignis Innovation Inc. Method and system for driving a light emitting device display
US9489891B2 (en) 2006-01-09 2016-11-08 Ignis Innovation Inc. Method and system for driving an active matrix display circuit
US9269322B2 (en) 2006-01-09 2016-02-23 Ignis Innovation Inc. Method and system for driving an active matrix display circuit
CA2570898C (en) 2006-01-09 2008-08-05 Ignis Innovation Inc. Method and system for driving an active matrix display circuit
HUP0600555A3 (en) * 2006-07-03 2008-10-28 Egis Gyogyszergyar Nyrt Use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]izoxazol-3-yl)piperidin-1-yl]ethylamino}2-methyl-3(2h)-piridazinon for the production of pharmaceutical compositions for influencing cognitive functions and causing neuroprotective effect
EP2277163B1 (de) 2008-04-18 2018-11-21 Ignis Innovation Inc. System und ansteuerverfahren für ein leuchtbauelement-display
CA2637343A1 (en) 2008-07-29 2010-01-29 Ignis Innovation Inc. Improving the display source driver
US9370075B2 (en) 2008-12-09 2016-06-14 Ignis Innovation Inc. System and method for fast compensation programming of pixels in a display
US8497828B2 (en) 2009-11-12 2013-07-30 Ignis Innovation Inc. Sharing switch TFTS in pixel circuits
CA2687631A1 (en) 2009-12-06 2011-06-06 Ignis Innovation Inc Low power driving scheme for display applications
CA2696778A1 (en) 2010-03-17 2011-09-17 Ignis Innovation Inc. Lifetime, uniformity, parameter extraction methods
US9351368B2 (en) 2013-03-08 2016-05-24 Ignis Innovation Inc. Pixel circuits for AMOLED displays
US20140368491A1 (en) 2013-03-08 2014-12-18 Ignis Innovation Inc. Pixel circuits for amoled displays
US9886899B2 (en) 2011-05-17 2018-02-06 Ignis Innovation Inc. Pixel Circuits for AMOLED displays
EP2715711A4 (de) 2011-05-28 2014-12-24 Ignis Innovation Inc System und verfahren zur schnellen kompensationsprogrammierung von pixeln auf einer anzeige
US9747834B2 (en) 2012-05-11 2017-08-29 Ignis Innovation Inc. Pixel circuits including feedback capacitors and reset capacitors, and display systems therefore
US9786223B2 (en) 2012-12-11 2017-10-10 Ignis Innovation Inc. Pixel circuits for AMOLED displays
US9336717B2 (en) 2012-12-11 2016-05-10 Ignis Innovation Inc. Pixel circuits for AMOLED displays
WO2014124755A1 (de) 2013-02-18 2014-08-21 Jürgen Von Der Ohe Verfahren und vorrichtung zum kaltstrahlreinigen
US9721505B2 (en) 2013-03-08 2017-08-01 Ignis Innovation Inc. Pixel circuits for AMOLED displays
CA2894717A1 (en) 2015-06-19 2016-12-19 Ignis Innovation Inc. Optoelectronic device characterization in array with shared sense line
CA2873476A1 (en) 2014-12-08 2016-06-08 Ignis Innovation Inc. Smart-pixel display architecture
CA2886862A1 (en) 2015-04-01 2016-10-01 Ignis Innovation Inc. Adjusting display brightness for avoiding overheating and/or accelerated aging
CA2898282A1 (en) 2015-07-24 2017-01-24 Ignis Innovation Inc. Hybrid calibration of current sources for current biased voltage progra mmed (cbvp) displays
US10657895B2 (en) 2015-07-24 2020-05-19 Ignis Innovation Inc. Pixels and reference circuits and timing techniques
US10373554B2 (en) 2015-07-24 2019-08-06 Ignis Innovation Inc. Pixels and reference circuits and timing techniques
CA2908285A1 (en) 2015-10-14 2017-04-14 Ignis Innovation Inc. Driver with multiple color pixel structure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
IL117646A (en) * 1995-04-12 2000-06-01 Ferrer Int 7-¬3-¬4-(6-fluoro-1,2-benzisoxazole-3-YL)piperidin-1-YL¾propoxy¾3-alkyl-chromen-4-ones their preparation their uses and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
HUP0103063A3 (en) 2005-06-28
KR20040030862A (ko) 2004-04-09
CZ2004123A3 (cs) 2004-05-12
ZA200400482B (en) 2005-05-25
PT1417206E (pt) 2010-07-29
US20040171619A1 (en) 2004-09-02
KR100909514B1 (ko) 2009-07-27
WO2003010166A1 (en) 2003-02-06
CN1247571C (zh) 2006-03-29
HUP0103063A2 (hu) 2003-02-28
US7098210B2 (en) 2006-08-29
PL367447A1 (en) 2005-02-21
AR088808A2 (es) 2014-07-10
SK552004A3 (en) 2004-08-03
DK1417206T3 (da) 2010-08-16
MXPA04000814A (es) 2004-05-21
AU2002321669A2 (en) 2003-02-17
SI1417206T1 (sl) 2010-09-30
CA2453917C (en) 2009-06-23
JP4249012B2 (ja) 2009-04-02
BR0211440A (pt) 2004-07-20
EA006246B1 (ru) 2005-10-27
MA27867A1 (fr) 2006-05-02
AR036248A1 (es) 2004-08-25
HK1067626A1 (en) 2005-04-15
EP1417206A1 (de) 2004-05-12
EP1417206B1 (de) 2010-05-05
ES2345541T3 (es) 2010-09-27
HU0103063D0 (en) 2001-10-28
CN1545513A (zh) 2004-11-10
NZ531154A (en) 2005-09-30
NO20040268L (no) 2004-03-23
AU2002321669B2 (en) 2008-05-15
CY1110240T1 (el) 2015-01-14
AU2002321669B8 (en) 2008-06-05
PL206824B1 (pl) 2010-09-30
CA2453917A1 (en) 2003-02-06
NO326155B1 (no) 2008-10-13
ATE466859T1 (de) 2010-05-15
EA200400223A1 (ru) 2004-12-30
HU225955B1 (en) 2008-01-28
JP2004538293A (ja) 2004-12-24

Similar Documents

Publication Publication Date Title
DE60236294D1 (de) Neue 2h-pyridazin-3-on derivate, pharmazeutische zusammensetzungen davon sowie ein verfahren zur herstellung derselben
ATE332898T1 (de) Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE60239200D1 (de) Isoliergraben und verfahren zu dessen herstellung
DE60132554D1 (de) STATORBLECHKöRPER UND VERFAHREN ZUR HERSTELLUNG DESSELBEN
DE60202175D1 (de) Formwerkzeug und Verfahren zu dessen Herstellung
DE60215851D1 (de) N-adamantylmethyl-derivate und zwischenprodukte als pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
DE50300813D1 (de) Neue fluorencarbonsaureester, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE60027721D1 (de) Bodenbelag, giessform und verfahren zur herstellung derselben
DE60129589D1 (de) Wabenfilter und verfahren zur herstellung desselben
ATE279178T1 (de) Verfahren zur kontinuierlichen herstellung inhalierfähiger arzneistoffe
DE50310782D1 (de) Piezoaktor und verfahren zu dessen herstellung
DE60032943D1 (de) Imid-benzoxazolpolykondensat sowie verfahren zur herstellung
ATE367152T1 (de) Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
DE60107833D1 (de) Veresterte polysaccharidprodukte, beta-lacton ringgeöffnete ketendimer-produkte enthaltende zusammensetzungen und verfahren zur deren herstellung
DE60213444D1 (de) Fluorpolymerlaminate und verfahren zur herstellung derselben
DE60224880D1 (de) Mikrobolometer und verfahren zu dessen herstellung
DE60304599D1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE290366T1 (de) Pharmazeutische formulierung mit überdecktem geschmack und verfahren zu ihrer herstellung
DE60218734D1 (de) Dehnbare verbundfolie und verfahren zu ihrer herstellung
DE60236171D1 (de) Verfahren for zur herstellung eines 14-hydroxynormorphinon-derivats
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
DE60323689D1 (de) Schräg geschichtetes furniermaterial und verfahren zu dessen herstellung
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
ATE409463T1 (de) Oral dispergierbare pharmazeutische zusammensetzung und verfahren zu ihrer herstellung
ATA3752003A (de) Verbundwerkstoff und verfahren zu dessen herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1417206

Country of ref document: EP

Representative=s name: STOLMAR & PARTNER, DE